Elting Kimberley A.

SEC source: 0000950170-24-072487 · ownership.xml · nonDerivative · entry 1

Elting Kimberley A. · CIK 0001605209 · President, Global Orthopedics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 227,747

F1 · balance_after: Includes 158,664 previously reported restriced stock units.

SEC source: 0000950170-24-044085 · ownership.xml · nonDerivative · entry 1

Elting Kimberley A. · CIK 0001605209 · President, Global Orthopedics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 232,014

F1 · balance_after: Includes 146,435 previously reported restriced stock units.

SEC source: 0000950170-24-041302 · ownership.xml · nonDerivative · entry 1

Elting Kimberley A. · CIK 0001605209 · President, Global Orthopedics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 234,952

F1 · balance_after: Includes 166,132 previously reported restricted stock units.

SEC source: 0000950170-24-011265 · ownership.xml · nonDerivative · entry 1

Elting Kimberley A. · CIK 0001605209 · President, Global Orthopedics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 236,983

F1 · balance_after: Includes 171,297 previously reported unvested restricted stock units.

SEC source: 0001209191-24-001245 · doc4.xml · nonDerivative · entry 2

Elting Kimberley A. · CIK 0001605209 · President, Global Orthopedics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 238,998

F2 · shares: The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered hereby on each of the first, second and third anniversaries of the Grant Date.

F1 · balance_after: Includes 157,609 previously reported unvested restricted stock units.

SEC source: 0001209191-24-001245 · doc4.xml · nonDerivative · entry 1

Elting Kimberley A. · CIK 0001605209 · President, Global Orthopedics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 220,187

F1 · balance_after: Includes 157,609 previously reported unvested restricted stock units.

SEC source: 0001209191-24-001032 · doc4.xml · nonDerivative · entry 1

Elting Kimberley A. · CIK 0001605209 · President, Global Orthopedics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 225,415

F1 · balance_after: Includes 169,318 previously reported unvested restricted stock units.

SEC source: 0001209191-23-056400 · doc4.xml · nonDerivative · entry 1

Elting Kimberley A. · CIK 0001605209 · President, Global Orthopedics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 227,193

F1 · shares: Represents time-based vesting restricted stock units that vest in full on the second anniversary of grant date.

F2 · balance_after: Includes 184,756 outstanding restricted stock units and 42,437 shares owned directly.

SEC source: 0001209191-23-024131 · doc4.xml · nonDerivative · entry 1

Elting Kimberley A. · CIK 0001605209 · President, Global Orthopedics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 177,841

F1 · balance_after: Includes 137,092 previously reported unvested restricted stock units.

SEC source: 0001209191-23-023448 · doc4.xml · nonDerivative · entry 1

Elting Kimberley A. · CIK 0001605209 · President, Global Orthopedics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 180,779

F1 · balance_after: Includes 144,560 previously reported unvested restricted stock units.

SEC source: 0001209191-23-007205 · doc4.xml · nonDerivative · entry 1

Elting Kimberley A. · CIK 0001605209 · President, Global Orthopedics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 183,164

F1 · balance_after: Includes 150,626 shares of unvested restricted stock units.

SEC source: 0001209191-24-001245 · doc4.xml · derivative · entry 3

Elting Kimberley A. · CIK 0001605209 · President, Global Orthopedics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,867

Underlying: Common Stock · 43,867 shares

Expires 2031-01-08

F3 · derivative.exercise_date: The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first anniversary of the Grant Date and one-twelfth (1/12th) of the shares covered thereby on each of the 15-month, 18-month, 21-month, 24-month, 27-month, 30-month, 33-month and 36-month anniversaries of the Grant Date.

SEC source: 0001209191-23-002664 · doc4.xml · derivative · entry 5

Elting Kimberley A. · CIK 0001605209 · President, Global Orthopedics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,566

Underlying: Common Stock · 84,566 shares

Expires 2033-01-05

F5 · derivative.exercise_date: The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first anniversary of the Grant Date and one-twelfth (1/12th) of the shares covered thereby on each of the 15-month, 18-month, 21-month, 24-month, 27-month, 30-month, 33-month and 36-month anniversaries of the Grant Date.

SEC source: 0001209191-23-002664 · doc4.xml · nonDerivative · entry 4

Elting Kimberley A. · CIK 0001605209 · President, Global Orthopedics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 185,179

F4 · shares: Represents outstanding performance stock units for awards granted in 2022, which as a result of the Orthofix Board's determination to treat the merger with SeaSpine Holdings Corporation as a change in control (referred to as a "corporate transaction" under Orthofix's Amended and Restated 2012 Long-Term Incentive Plan) were deemed achieved at target levels as of the merger date and converted to time-based awards that vest on January 31, 2025.

SEC source: 0001209191-23-002664 · doc4.xml · nonDerivative · entry 3

Elting Kimberley A. · CIK 0001605209 · President, Global Orthopedics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 164,687

F3 · shares: Represents outstanding performance stock units for awards granted in 2021, which as a result of the Orthofix Board's determination to treat the merger with SeaSpine Holdings Corporation as a change in control (referred to as a "corporate transaction" under Orthofix's Amended and Restated 2012 Long-Term Incentive Plan) were deemed achieved at target levels as of the merger date and converted to time-based awards that vest on April 1, 2024.

SEC source: 0001209191-23-002664 · doc4.xml · nonDerivative · entry 2

Elting Kimberley A. · CIK 0001605209 · President, Global Orthopedics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 152,458

F2 · shares: Represents outstanding performance stock units for awards granted in 2020, which as a result of the Orthofix Board's determination to treat the merger with SeaSpine Holdings Corporation as a change in control (referred to as a "corporate transaction" under Orthofix's Amended and Restated 2012 Long-Term Incentive Plan) were deemed achieved at target levels as of the merger date and converted to time-based awards that vest on June 8, 2023.

SEC source: 0001209191-23-002664 · doc4.xml · nonDerivative · entry 1

Elting Kimberley A. · CIK 0001605209 · President, Global Orthopedics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 140,924

F1 · shares: The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered hereby on each of the first, second and third anniversaries of the Grant Date.

SEC source: 0001209191-23-002113 · doc4.xml · nonDerivative · entry 1

Elting Kimberley A. · CIK 0001605209 · President, Global Orthopedics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 105,795

F1 · shares: Represents time-based vesting restricted stock units that vest in 1/3 increments on the first, second and third anniversaries of grant date, January 3, 2023.

F2 · balance_after: Includes 76,365 shares of unvested restricted stock units.

SEC source: 0001209191-22-049010 · doc4.xml · nonDerivative · entry 1

Elting Kimberley A. · CIK 0001605209 · President, Global Orthopedics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,085

SEC source: 0001209191-22-024288 · doc4.xml · nonDerivative · entry 1

Elting Kimberley A. · CIK 0001605209 · President, Global Orthopedics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,450

F1 · shares: Represents time-based vesting restricted stock units that vest in 25% increments on the first, second, third and forth anniversaries of the grant date, April 11, 2022.

SEC source: 0001209191-22-023337 · doc4.xml · nonDerivative · entry 4

Elting Kimberley A. · CIK 0001605209 · Chief Legal & Develop. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,576

SEC source: 0001209191-22-023337 · doc4.xml · nonDerivative · entry 3

Elting Kimberley A. · CIK 0001605209 · Chief Legal & Develop. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,910

SEC source: 0001209191-22-023337 · doc4.xml · nonDerivative · entry 2

Elting Kimberley A. · CIK 0001605209 · Chief Legal & Develop. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,112

SEC source: 0001209191-22-023337 · doc4.xml · nonDerivative · entry 1

Elting Kimberley A. · CIK 0001605209 · Chief Legal & Develop. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,941

SEC source: 0001209191-22-006837 · doc4.xml · derivative · entry 2

Elting Kimberley A. · CIK 0001605209 · Chief Legal & Develop. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,492

Underlying: Common Stock · 20,492 shares

Expires not disclosed

F2 · derivative.exercise_date: Represents performance-based vesting restricted stock units ("PSUs") that will settle as common stock on a one-for-one basis. Under the terms of the grant, the PSUs may vest based upon achieved product revenues for the 2023 fiscal year (the "Product Revenue Vesting Percentage"), as modified by a total shareholder return ("TSR") modifier (the "TSR Modifier"). The amount in the table above represents the target number of PSUs granted. The performance period of the grant is 2/1/22-1/31/25. The Product Revenue Vesting Percentage can be achieved within a range of 50% to 200% of target, based upon the level of recognized revenues. If the Product Revenue Vesting Percentage is achieved at or above the threshold level, it shall be multiplied by the TSR Modifier (ranging from 0.75 to 1.25), which shall be determined based on the Company's relative TSR during the performance period as compared to a specified peer group.

F2 · derivative.expiration_date: Represents performance-based vesting restricted stock units ("PSUs") that will settle as common stock on a one-for-one basis. Under the terms of the grant, the PSUs may vest based upon achieved product revenues for the 2023 fiscal year (the "Product Revenue Vesting Percentage"), as modified by a total shareholder return ("TSR") modifier (the "TSR Modifier"). The amount in the table above represents the target number of PSUs granted. The performance period of the grant is 2/1/22-1/31/25. The Product Revenue Vesting Percentage can be achieved within a range of 50% to 200% of target, based upon the level of recognized revenues. If the Product Revenue Vesting Percentage is achieved at or above the threshold level, it shall be multiplied by the TSR Modifier (ranging from 0.75 to 1.25), which shall be determined based on the Company's relative TSR during the performance period as compared to a specified peer group.

SEC source: 0001209191-22-006837 · doc4.xml · nonDerivative · entry 1

Elting Kimberley A. · CIK 0001605209 · Chief Legal & Develop. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,295

F1 · shares: Represents time-based vesting restricted stock units that vest in 25% increments on the first, second, third and fourth anniversaries of the grant date, February 1, 2022.

SEC source: 0001209191-21-065545 · doc4.xml · nonDerivative · entry 1

Elting Kimberley A. · CIK 0001605209 · Chief Legal & Develop. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,803

SEC source: 0001209191-21-055054 · doc4.xml · nonDerivative · entry 1

Elting Kimberley A. · CIK 0001605209 · Chief Legal & Develop. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,953

SEC source: 0001209191-21-045860 · doc4.xml · nonDerivative · entry 1

Elting Kimberley A. · CIK 0001605209 · Chief Legal & Develop. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,318

SEC source: 0001209191-21-025412 · doc4.xml · nonDerivative · entry 5

Elting Kimberley A. · CIK 0001605209 · Chief Legal & Develop. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,217

SEC source: 0001209191-21-025412 · doc4.xml · derivative · entry 6

Elting Kimberley A. · CIK 0001605209 · Chief Legal & Develop. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,229

Underlying: Common Stock · 12,229 shares

Expires not disclosed

F2 · derivative.exercise_date: Represents market-based vesting performance stock units ("PSUs") that will settle as common stock on a one-for-one basis. The performance period of the grant is defined as April 1, 2021 to April 1, 2024. The PSUs will vest based on the percentile rank of the Company's total shareholder return ("TSR") over the performance period in relation to the TSR of the specified index companies. The index companies are based upon the companies included within the S&P 600 Health Care Equipment & Services Industry Group Index (S6HCES) as of April 1, 2021, the grant date. In the event that the Company's TSR ranks at the 75th percentile or greater for the performance period, 200% of the PSUs will vest. In the event that the Company's TSR ranks between the 50th percentile and the 75th percentile, 100-200% of the PSUs will vest and 50-100% of the PSUs will vest if the Company's TSR ranks between the 25th percentile and 50th percentile. No PSUs will vest if the Company ranks below the 25th percentile.

F2 · derivative.expiration_date: Represents market-based vesting performance stock units ("PSUs") that will settle as common stock on a one-for-one basis. The performance period of the grant is defined as April 1, 2021 to April 1, 2024. The PSUs will vest based on the percentile rank of the Company's total shareholder return ("TSR") over the performance period in relation to the TSR of the specified index companies. The index companies are based upon the companies included within the S&P 600 Health Care Equipment & Services Industry Group Index (S6HCES) as of April 1, 2021, the grant date. In the event that the Company's TSR ranks at the 75th percentile or greater for the performance period, 200% of the PSUs will vest. In the event that the Company's TSR ranks between the 50th percentile and the 75th percentile, 100-200% of the PSUs will vest and 50-100% of the PSUs will vest if the Company's TSR ranks between the 25th percentile and 50th percentile. No PSUs will vest if the Company ranks below the 25th percentile.

SEC source: 0001209191-21-025412 · doc4.xml · nonDerivative · entry 4

Elting Kimberley A. · CIK 0001605209 · Chief Legal & Develop. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,552

SEC source: 0001209191-21-025412 · doc4.xml · nonDerivative · entry 3

Elting Kimberley A. · CIK 0001605209 · Chief Legal & Develop. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,381

SEC source: 0001209191-21-025412 · doc4.xml · nonDerivative · entry 2

Elting Kimberley A. · CIK 0001605209 · Chief Legal & Develop. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,366

SEC source: 0001209191-21-025412 · doc4.xml · nonDerivative · entry 1

Elting Kimberley A. · CIK 0001605209 · Chief Legal & Develop. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,720

F1 · shares: Represents time-based vesting restricted stock units that vest in 25% increments on the first, second, third and fourth anniversaries of the grant date, April 1, 2021.

SEC source: 0001209191-20-052236 · doc4.xml · nonDerivative · entry 1

Elting Kimberley A. · CIK 0001605209 · Chief Legal & Develop. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,965

SEC source: 0001209191-20-050550 · doc4.xml · nonDerivative · entry 1

Elting Kimberley A. · CIK 0001605209 · Chief Legal & Develop. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,515

SEC source: 0001209191-20-041308 · doc4.xml · nonDerivative · entry 1

Elting Kimberley A. · CIK 0001605209 · Chief Legal & Admin Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,880

SEC source: 0001209191-20-035645 · doc4.xml · derivative · entry 1

Elting Kimberley A. · CIK 0001605209 · Chief Legal & Admin Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,534

Underlying: Common Stock · 11,534 shares

Expires not disclosed

F1 · derivative.exercise_date: Represents market-based vesting performance stock units ("PSUs") that will settle as common stock on a one-for-one basis. The performance period of the grant is defined as June 8, 2020 to June 8, 2023. The PSUs will vest based on the percentile rank of the Company's total shareholder return ("TSR") over the performance period in relation to the TSR of the specified index companies. The index companies are based upon the companies included within the S&P Healthcare Select Sector index as of June 8, 2020, the grant date. In the event that the Company's TSR ranks at the 75th percentile or greater for the performance period, 200% of the PSUs will vest. In the event that the Company's TSR ranks between the 50th percentile and the 75th percentile, 100-200% of the PSUs will vest and 50-100% of the PSUs will vest if the Company's TSR ranks between the 25th percentile and 50th percentile. No PSUs will vest if the Company ranks below the 25th percentile.

F1 · derivative.expiration_date: Represents market-based vesting performance stock units ("PSUs") that will settle as common stock on a one-for-one basis. The performance period of the grant is defined as June 8, 2020 to June 8, 2023. The PSUs will vest based on the percentile rank of the Company's total shareholder return ("TSR") over the performance period in relation to the TSR of the specified index companies. The index companies are based upon the companies included within the S&P Healthcare Select Sector index as of June 8, 2020, the grant date. In the event that the Company's TSR ranks at the 75th percentile or greater for the performance period, 200% of the PSUs will vest. In the event that the Company's TSR ranks between the 50th percentile and the 75th percentile, 100-200% of the PSUs will vest and 50-100% of the PSUs will vest if the Company's TSR ranks between the 25th percentile and 50th percentile. No PSUs will vest if the Company ranks below the 25th percentile.

SEC source: 0001209191-20-023323 · doc4.xml · nonDerivative · entry 3

Elting Kimberley A. · CIK 0001605209 · Chief Legal & Admin Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,009

SEC source: 0001209191-20-023323 · doc4.xml · derivative · entry 4

Elting Kimberley A. · CIK 0001605209 · Chief Legal & Admin Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,996

Underlying: Common Stock · 26,996 shares

Expires 2030-04-01

F2 · derivative.exercise_date: These stock options vest in 25% increments on the first, second, third and fourth anniversaries of the grant date, April 1, 2020.

SEC source: 0001209191-20-023323 · doc4.xml · nonDerivative · entry 2

Elting Kimberley A. · CIK 0001605209 · Chief Legal & Admin Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,344

F1 · shares: Represents time-based vesting restricted stock units that vest in 25% increments on the first, second, third and fourth anniversaries of the grant date, April 1, 2020.

SEC source: 0001209191-20-023323 · doc4.xml · nonDerivative · entry 1

Elting Kimberley A. · CIK 0001605209 · Chief Legal & Admin Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,912

SEC source: 0001209191-19-050987 · doc4.xml · nonDerivative · entry 1

Elting Kimberley A. · CIK 0001605209 · Chief Legal & Admin Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,499

SEC source: 0001209191-19-048742 · doc4.xml · nonDerivative · entry 1

Elting Kimberley A. · CIK 0001605209 · Chief Legal & Admin Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,049

SEC source: 0001209191-19-042095 · doc4.xml · nonDerivative · entry 1

Elting Kimberley A. · CIK 0001605209 · Chief Legal & Admin Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,414

SEC source: 0001209191-19-024370 · doc4.xml · nonDerivative · entry 1

Elting Kimberley A. · CIK 0001605209 · Chief Legal & Admin Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,760

SEC source: 0001209191-19-023373 · doc4.xml · derivative · entry 4

Elting Kimberley A. · CIK 0001605209 · Chief Legal & Admin Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,206

Underlying: Common Stock · 7,206 shares

Expires 2022-04-01

F4 · derivative.exercise_date: Represents market-based vesting performance stock units ("PSUs") that will settle as common stock on a one-for-one basis. The performance period of the grant is defined as April 1, 2019 to April 1, 2022. The PSUs will vest based on the percentile rank of the Company's total shareholder return ("TSR") over the performance period in relation to the TSR of the specified index companies. The index companies are based upon the companies included within the S&P Healthcare Select Sector index as of April 1, 2019, the grant date. In the event that the Company's TSR ranks at the 75th percentile or greater for the performance period, 200% of the PSUs will vest. In the event that the Company's TSR ranks between the 50th percentile and the 75th percentile, 100-200% of the PSUs will vest and 50-100% of the PSUs will vest if the Company's TSR ranks between the 25th percentile and 50th percentile. No PSUs will vest if the Company ranks below the 25th percentile.

SEC source: 0001209191-19-023373 · doc4.xml · derivative · entry 3

Elting Kimberley A. · CIK 0001605209 · Chief Legal & Admin Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,939

Underlying: Common Stock · 11,939 shares

Expires 2029-04-01

F3 · derivative.exercise_date: These stock options vest in 25% increments on the first, second, third and fourth anniversaries of the grant date, April 1, 2019.

SEC source: 0001209191-19-023373 · doc4.xml · nonDerivative · entry 2

Elting Kimberley A. · CIK 0001605209 · Chief Legal & Admin Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,095

F2 · shares: Represents time-based vesting restricted stock units that vest on the second anniversary of the grant date, April 1, 2019.